Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Kidney Neoplasms 2Breast Neoplasms 2Sarcoma, Kaposi 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Leukemia 1Carcinoma, Renal Cell 1AIDS-related Kaposi sarcoma 1

Interventions

Zidovudine 6tecogalan 4Vincristine 3Specimen Handling 3Nivolumab 3Magnetic Resonance Spectroscopy 3Interferon alpha-2 3Doxorubicin 3Bleomycin 3sargramostim 2pomalidomide 2pembrolizumab 2liposomal doxorubicin 2interferon alfa-n1 2Etoposide 2Docetaxel 2Biopsy 2valspodar 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1entinostat 1efineptakin alfa 1cabozantinib 1Zalcitabine 1Tumor Necrosis Factor-alpha 1Thalidomide 1Sorafenib 1Sirolimus 1Semaxinib 1SUB1 protein, human 1O-(Chloroacetylcarbamoyl)fumagillol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Sarcoma, Kaposi × valspodar × Clear all
NCT00003207 2013-04-12

Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers

Washington University School of Medicine

Phase 1 Completed
14 enrolled
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡